Wernli Miri Halperin has filed 6 insider transactions across 1 company since March 2023.
Most recent transaction: a option exercise of 50000 shares of Definium Therapeutics, Inc. ($DFTX) on August 21, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 21, 2024 | Definium Therapeutics, Inc. | $DFTX | Halperin Wernli Miri | Executive President | M | Common Shares | 50000 | $3.70 | 235,000.0000 | 0 | 27.03% | 0.00% |
| Aug. 21, 2024 | Definium Therapeutics, Inc. | $DFTX | Halperin Wernli Miri | Executive President | F | Common Shares | 32595 | $6.17 | 202,405.0000 | 0 | 13.87% | 0.00% |
| Aug. 21, 2024 | Definium Therapeutics, Inc. | $DFTX | Halperin Wernli Miri | Executive President | M | Stock Option (Right to Buy) | 50000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 27, 2024 | Definium Therapeutics, Inc. | $DFTX | Wernli Miri Halperin | Executive President | A | Stock Option (Right to Buy) | 125000 | $0.00 | 125,000.0000 | 0 | 9999.99% | 0.00% |
| March 14, 2023 | Definium Therapeutics, Inc. | $DFTX | Wernli Miri Halperin | Executive President | A | Common Shares | 100000 | $0.00 | 185,000.0000 | 0 | 117.65% | 0.00% |
| March 14, 2023 | Definium Therapeutics, Inc. | $DFTX | Wernli Miri Halperin | Executive President | A | Common Shares | 100000 | $0.00 | 1,375,000.0000 | 0 | 7.84% | 0.00% |